Revelstoke Capital Partners has completed an investment in Crossroads Holding, which provides substance abuse treatment services through outpatient clinics in the southeastern U.S. Quadriga Partners worked as financial advisor to Crossroads.
Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm, has completed an investment in Crossroads Holding, LLC (“Crossroads” or the “Company”).
Crossroads, based in Greenville, South Carolina, is a leading regional provider of substance abuse treatment services through its outpatient treatment clinics in the southeastern United States. Crossroads provides physician oversight, counseling and medication-assisted treatment through its nationally-accredited outpatient program that delivers effective and affordable treatment for persons suffering from opioid dependence. Revelstoke will provide Crossroads strategic guidance and additional capital to accelerate its organic growth, pursue selective acquisitions and continue to leverage its scalable business model.
“We are excited about the prospect of working with an extremely talented and experienced management team to grow the Company and further solidify its position as a leader in the substance abuse treatment industry,” said Mark King, CEO, Managing Partner and Co-Founder of Revelstoke. “Crossroads offers its patients a path to end the destructive cycle of emotional, physical and financial calamity that chemical dependence causes, and Revelstoke is enthusiastic to partner in this continued effort.”
“The resources and expertise that Revelstoke brings to our team allows us to continue our focus on growth while maintaining the quality and efficacy of our treatment program,” remarked Dr. Rupert McCormac IV, Founder, CEO, and Chief Medical Officer of Crossroads. Dr. McCormac will be joined on the Board by Co-Founder Steve Kester to provide continuity of leadership.
Winston & Strawn LLP acted as exclusive legal advisor to Revelstoke. Quadriga Partners, LLC served as exclusive financial advisor and Perkins Coie LLP acted as exclusive legal advisor to Crossroads in the transaction.
Crossroads is a leading provider of medication-assisted treatment services for individuals who are opioid dependent through its established outpatient care centers located throughout the southeastern United States. Crossroads was founded in 2007 and is headquartered in Greenville, South Carolina.
Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading companies. Revelstoke strives to partner with management teams to execute on a disciplined organic and acquisition strategy to build exceptional companies. Revelstoke’s Managing Partners, Mark King, Dale Meyer and Simon Bachleda, have completed over 100 platform and add-on acquisitions, representing over $5 billion of total enterprise value.